跳至主要内容
临床试验/2024-516864-27-00
2024-516864-27-00招募中2 期

CardioPulmonary resuscitation with Argon (CPAr) trial

Istituto Di Ricerche Farmacologiche Mario Negri10 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年10月7日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
120
试验地点
10
主要终点
48 h Serum Neuron Specific Enolase (NSE) concentration for evaluation of Ar activity on neuronal preservation.

研究概览

简要总结

The objective of the CPAr trial is to evaluate the efficacy in reducing post-CA neurological injury of Ar 70%/O2 30% ventilation in patients resuscitated from OHCA with an experimental ventilator, specifically modified to permit Ar/O2 ventilation.

研究设计

分配方式
Randomized
主要目的
CardioPulmonary resuscitation with Argon (CPAr) trial
盲法
None

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • witnessed non-traumatic OHCA of presumably cardiac etiology with a presenting shockable rhythm
  • age ≥ 18 years
  • unconsciousness after return of spontaneous circulation (ROSC)
  • duration of CPR ≤ 40 mins
  • Initiation of study intervention ≤ 4 hrs from ROSC
  • stable SaO2 ≥ 94% (according to the physician’s criteria), with a FiO2 of 30%

排除标准

  • age < 18 years
  • initiation of the study intervention > 4 hrs from ROSC
  • participation to another clinical trial
  • non-witnessed CA
  • CA of traumatic origin
  • non-presumably cardiac cause
  • non-shockable presenting rhythm (pulseless electrical activity and asystole)
  • women of childbearing potential defined as younger of 50 years
  • known terminal illness
  • pre-CA cerebral performance category (CPC) ≥ 3

结局指标

主要结局

48 h Serum Neuron Specific Enolase (NSE) concentration for evaluation of Ar activity on neuronal preservation.

48 h Serum Neuron Specific Enolase (NSE) concentration for evaluation of Ar activity on neuronal preservation.

次要结局

  • hs-cTnT plasma concentration for evaluation of Ar activity on myocardial preservation;
  • Brain imaging (MRI with DWI and DTI, in patients that remain comatose), for evaluation of Ar activity on neuronal preservation;
  • Multiorgan function (circulating biomarkers);
  • Survival and CPC score up to 6 months, for evaluation of functional outcome.

研究者

申办方类型
Laboratory/Research/Testing facility
责任方
Principal Investigator
主要研究者

Roberto Latini

Scientific

Istituto Di Ricerche Farmacologiche Mario Negri

研究点 (10)

Loading locations...

相似试验

CardioPulmonary resuscitation with Argon (CPAr) trial | 临床试验